A study funded by the Mayo Clinic and published in Circulation: Arrhythmia and Electrophysiology this week suggests AI could be successfully applied to ECG data to measure a person’s overall health status.

Newly diagnosed HF patients with concomitant mitral regurgitation can expect more admissions, longer hospital stays and pricier medical bills than HF patients without MR, according to an analysis published in the American Journal of Cardiology.

A team of University of Texas at Austin researchers are looking to replace the decades-old electrocardiography process with a more comprehensive, streamlined way to monitor heart health: e-tattoos.

Royal Philips has rolled out the latest update for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems, expanding to include automated applications for 2D assessment of the heart and robust 3D measurements of right ventricular volume and ejection fraction.

AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

Omron Healthcare launched its latest innovation, Complete, May 1, marking the first time a blood pressure (BP) monitor with electrocardiogram (ECG) capabilities has hit the commercial market.

Cardio-oncology has emerged as an area of rapid growth in the medical community in recent years, owing in large part to an increasing population of cancer survivors.

Catheter-directed therapy (CDT) is being used to treat pulmonary embolism (PE) more and more by healthcare providers, according to new research published in the Journal of Vascular and Interventional Radiology.